Stifel analyst Jonathan Block raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $460 and keeps a Hold rating on the shares after revisiting Q1 earnings reports across the analyst’s Animal Health, Dental and Sleep Apnea coverage.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- IDEXX Laboratories Updates Corporate Governance Structure
- Idexx Laboratories: Resilience and Growth Potential Amidst Challenging Conditions
- IDEXX Laboratories Reports Strong Q1 2025 Results
- IDEXX Laboratories’ Earnings Call: Strong Growth Amid Challenges
- Idexx Laboratories: Promising Developments Balanced by Market Challenges Leading to Hold Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue